Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
Gilead Sciences Inc. closed 0.11% below its 52-week high of $112.11, which the company reached on February 25th.
Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...
The Health and Human Services Department is reviewing contracts and moving to replace vaccine advisers in Robert F. Kennedy Jr.’s first few ...
6h
Hosted on MSNThe Handmaid's Tale Sequel Show Casts Its Young Protagonist With A Connection To GileadHulu’s The Testaments casts its Daisy, a Canadian teen whose world is upended when she discovers her hidden connection to ...
Investors eyeing high-growth stocks should consider Corcept Therapeutics, TKO Group, and others with strong earnings ...
Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...
The Testaments, the sequel series to The Handmaid’s Tale, has cast a major leading role. The upcoming series, based on ...
The Handmaid’s Tale creator Bruce Miller has reportedly been working on the show for “several years” now, and stepped down as ...
Hulu’s upcoming series “ The Testaments ,” a sequel to “The Handmaid’s Tale,” has cast Lucy Halliday in the role of Daisy.
Hulu confirmed Lucy Halliday will be appearing in The Testaments, The Handmaid's Tale sequel, and she is going to portray Daisy, the role of one of the trio of lead female characters in the series, Va ...
Lucy Halliday (Blue Jean) has been tapped as a lead opposite Chase Infiniti and Ann Dowd in The Handmaid’s Tale sequel The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results